FOXO4-DRI (10mg) USA – Advanced Senolytic & Anti-Aging Research Peptide
FOXO4-DRI (10mg) is a cutting-edge research peptide widely studied for its potential role in senescent cell removal, anti-aging research, and cellular regeneration. Manufactured in the USA under strict laboratory standards, FOXO4-DRI has garnered attention for its ability to target and neutralize senescent cells, making it a valuable tool in studies focused on age-related diseases, longevity research, and regenerative medicine.
FOXO4-DRI is a synthetic peptide designed to disrupt the interaction between FOXO4 and p53 proteins in senescent cells. This targeted mechanism allows researchers to selectively induce apoptosis in senescent cells while sparing healthy tissue, providing critical insights into cellular aging pathways and regenerative biology.
The FOXO4-DRI (10mg) peptide is commonly used in laboratories investigating cellular senescence, tissue regeneration, and anti-aging interventions, positioning it as a pivotal research compound in biogerontology, regenerative medicine, and age-related disease studies.
What is FOXO4-DRI?
FOXO4-DRI (FOXO4–D-Retro-Inverso) is a synthetic peptide that targets senescent cells by disrupting the FOXO4-p53 interaction, which normally helps these aged cells evade apoptosis. Senescent cells are metabolically active but no longer divide, and their accumulation is associated with tissue dysfunction, inflammation, and age-related pathologies.
By selectively inducing apoptosis in senescent cells, FOXO4-DRI allows researchers to explore mechanisms for:
-
Cellular rejuvenation and tissue repair
-
Age-related disease intervention
-
Reduction of chronic inflammation caused by senescent cells
-
Enhanced regenerative medicine outcomes
-
Anti-aging therapeutic research
This selective senolytic activity makes FOXO4-DRI a powerful peptide for studying longevity and cellular health.
Key Benefits of FOXO4-DRI (10mg) in Research
Supports Senolytic Research
FOXO4-DRI is widely studied for its ability to target and remove senescent cells, providing laboratories with a tool to investigate cellular rejuvenation and anti-aging pathways.
Promotes Anti-Aging and Longevity Studies
By clearing senescent cells, FOXO4-DRI helps researchers explore mechanisms of longevity, tissue regeneration, and age-related decline mitigation.
Enhances Regenerative Medicine Research
FOXO4-DRI facilitates studies on cellular repair and regeneration, particularly in tissues affected by senescent cell accumulation.
Reduces Inflammation Research
Senescent cells contribute to chronic low-grade inflammation. FOXO4-DRI is studied for its potential role in modulating inflammation associated with aging and tissue dysfunction.
Valuable Research Tool in Age-Related Disease Studies
Its targeted action allows scientists to investigate senescence-related diseases, including fibrosis, metabolic dysfunction, and degenerative conditions, in a controlled research environment.
Precision Laboratory Peptide
As a synthetic D-retro-inverso peptide, FOXO4-DRI provides high specificity, reproducibility, and reliability, enabling precise experimental studies on cellular aging and senolytic interventions.
Why Choose FOXO4-DRI (10mg) USA?
-
High-Purity Research Grade: Manufactured under strict laboratory standards for maximum purity and consistency.
-
Accurate 10mg Dosage: Each vial contains precisely measured peptide content for reliable research applications.
-
Trusted USA Supplier: Produced and packaged with verified quality control to ensure laboratory-grade reliability.
-
Specialized Senolytic Peptide: Designed for research in cellular aging, anti-aging interventions, and regenerative medicine.
Research Applications
The FOXO4-DRI (10mg) peptide is commonly used in laboratory research involving:
-
Cellular senescence and apoptosis studies
-
Anti-aging and longevity research
-
Tissue regeneration and repair studies
-
Senolytic therapy research
-
Age-related disease research
-
Inflammation modulation and chronic disease studies
-
Regenerative medicine and peptide therapy studies
Its targeted effects on senescent cells and regenerative pathways make FOXO4-DRI a valuable tool for laboratories studying aging, tissue regeneration, and cellular health.
Storage and Handling
To maintain peptide stability and potency:
-
Store in a cool, dry environment
-
Refrigerate after reconstitution
-
Protect from heat and direct sunlight
-
Use sterile laboratory techniques when handling
Proper storage ensures maximum peptide stability and research accuracy.
Important Notice
FOXO4-DRI (10mg) is intended strictly for research and laboratory use in the USA. This product is not approved for human consumption outside regulated scientific studies. Researchers should follow proper laboratory safety protocols when handling peptides.
Conclusion
The FOXO4-DRI (10mg) USA peptide is a specialized research compound used in laboratories studying senescence, anti-aging, and regenerative medicine.
With its potential role in selective senescent cell removal, tissue regeneration, and longevity research, FOXO4-DRI has become an essential tool in modern biogerontology and regenerative peptide studies.
Thanks to high purity, precise dosage, and targeted senolytic activity, FOXO4-DRI (10mg) provides researchers with a reliable and versatile peptide for studying cellular rejuvenation, age-related disease mechanisms, and regenerative biology.
Reviews
There are no reviews yet.